Video:

2022 International Conference on Advanced Technologies & Treatments for Diabetes (ATTD): Remote Monitoring in France and AI, Machine Learning & DTx for Behavioral Modification

During the 2022 International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) pre-event symposium sessions, diabetes industry leaders presented insights on digital health.

Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. shared the benefits of using AI, machine learning and digital therapeutics to create a customized care and more tailored therapy regimen for people with diabetes and related chronic conditions.

Professor Charles Thivolet, cofounder of the DIAB-eCARE Diabetes Center at Hospices Civils de Lyon, discussed how remote monitoring is used as a tool for improving care for people with diabetes in France.

Watch the presentations to learn about the power of technology being used to monitor and care for people with diabetes and related chronic conditions.